is tirzepatide red Why My in Colour? Safety Guide Tirzepatide Treatment | Longevity Direct

Contact now to schedule an appointment and loose weight quickly and safely

Yuichiro Yamada at Akita University for generously donating the tagged human GLP-1R cytomegalovirus promoter vector (pCMV)

Weight Loss Comparison: Injectable Semaglutide (Wegovy 2.4 mg weekly): Average weight loss: 14.9% of body weight Duration: 68 weeks Patients losing 5%+: 86.4% Patients losing 10%+: 69.1% Patients losing 15%+: 50.5% Injectable Tirzepatide (Zepbound 15 mg weekly): Average weight loss: 22.5% of body weight Duration: 72 weeks Patients losing 5%+: 96% Patients losing 10%+: 89% Patients losing 15%+: 78% Patients losing 20%+: 63% Oral Semaglutide (Rybelsus 14 mg daily): Average weight loss: 3-5% of body weight Duration: 26-52 weeks depending on study Patients losing 5%+: Approximately 30-40% Patients losing 10%+: Less than 10% Patients losing 15%+: Rare Real-World Weight Loss Examples: Starting Weight: 250 pounds Starting Weight: 200 pounds Why Such a Big Difference

More research in this area is needed before we know for sure whether tirzepatide is safe to use during breastfeeding

Patients should be counseled to monitor urine color (pale yellow indicating adequate hydration) and to increase fluid intake during exercise or hot weather

But exercise-wise, lifting is your strongest lever